Entero Therapeutics (ENTO) Stock Chart & Stock Price History $0.48 +0.00 (+0.38%) As of 03:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Entero Therapeutics Stock Price Performance The Entero Therapeutics (ENTO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 52.02%, with a year-to-date return of -23.63%. In the past month, the stock has decreased 1.92%, reflecting recent market activity. As of the latest close, Entero Therapeutics traded at $0.47 with a market cap of $2.26 million and volume of 341,031 shares. Receive ENTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.06%1 Month Performance-1.92%3 Month Performance+25.59%Year-To-Date Performance-23.63%1 Year Performance-52.02% ENTO Stock Chart for Friday, July, 18, 2025 ENTO Chart by TradingView Entero Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$0.45$0.47+4.92%$0.48$0.44341,031 shs$2.26 million07/16/2025$0.47$0.45-4.04%$0.47$0.45107,512 shs$2.15 million07/15/2025$0.48$0.47-2.43%$0.47$0.43205,875 shs$2.24 million07/14/2025$0.49$0.48-1.69%$0.51$0.45348,499 shs$2.30 million07/11/2025$0.49$0.49+0.62%$0.49$0.46282,610 shs$2.34 million07/10/2025$0.55$0.49-11.26%$0.49$0.45682,609 shs$2.32 million07/09/2025$0.53$0.55+3.53%$0.57$0.4421.00 million shs$2.62 million07/08/2025$0.40$0.53+33.53%$0.57$0.393.67 million shs$2.53 million07/07/2025$0.40$0.40-1.73%$0.41$0.3971,840 shs$1.89 million07/04/2025$0.40$0.40$0.41$0.4068,057 shs$1.93 million Get the Latest News and Ratings for ENTO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$0.41$0.40-0.25%$0.41$0.4068,057 shs$1.93 million07/02/2025$0.39$0.41+3.71%$0.41$0.3996,379 shs$1.93 million07/01/2025$0.40$0.39-2.38%$0.41$0.3978,341 shs$1.86 million06/30/2025$0.38$0.40+5.54%$0.40$0.36156,788 shs$1.91 million06/27/2025$0.44$0.38-12.87%$0.45$0.36439,071 shs$1.81 million06/26/2025$0.46$0.44-5.86%$0.52$0.431.05 million shs$2.08 million06/25/2025$0.48$0.46-3.18%$0.48$0.45204,827 shs$2.20 million06/24/2025$0.50$0.48-4.62%$0.52$0.46236,629 shs$2.28 million06/23/2025$0.53$0.50-5.76%$0.52$0.48249,284 shs$2.39 million06/20/2025$0.48$0.53+9.64%$0.57$0.451.77 million shs$2.53 million06/19/2025$0.48$0.48$0.51$0.46138,459 shs$2.31 million06/18/2025$0.47$0.48+3.15%$0.51$0.46138,459 shs$2.31 million06/17/2025$0.50$0.47-6.12%$0.53$0.43372,766 shs$2.24 million Related Companies Chromocell Therapeutics Stock Chart Traws Pharma Stock Chart Talphera Stock Chart Turnstone Biologics Stock Chart Aptorum Group Stock Chart Biomerica Stock Chart ObsEva Stock Chart NLS Pharmaceutics Stock Chart Cardio Diagnostics Stock Chart Biofrontera Stock Chart Receive ENTO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENTO) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENTO Stock Alerts